Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

Benzinga Newsdesk www.benzinga.com Positive 76.7%

Neg 0% Neu 0% Pos 76.7%

Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.